HCPCS Code Details - Q5119

HCPCS Level II Code
Miscellaneous Services (Temporary Codes)
HCPCS Code Q5119
Description

Long description:
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

Short description:
Inj ruxience, 10 mg

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
ASC payment group code Effective Jul 01, 2020 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2020
Date added Added Jul 01, 2020
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - Q5119

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
April 1, 2024 - June 30, 2024 10 MG 20.275 - - - - - -
January 1, 2024 - March 31, 2024 10 MG 20.447 - - - - - -
October 1, 2023 - December 31, 2023 10 MG 22.304 20% - - - - -
Jul 1, 2023 - Sep 30, 2023 10 MG 27.509 20% - - - - -
April 1, 2023 - June 30, 2023 10 MG 29.974 20% - - - - -

See also

  • HCPCS Q5118 · Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

  • HCPCS Q5120 · Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”